M
Power Law company profile
Merus
Biotech & Life Sciences · Utrecht, Netherlands · Founded 2003 · IPO 2016 Unicorn
Valuation
$6.20B
Market cap · Jan/2026
Revenue
$36M
Latest reported FY
Global footprint
Where Merus has talent and traffic
AI talent share
0.8%
of workforce is AI talent
(2 of 262 staff)
(2 of 262 staff)
Core AI20.76%
Other AI00%
Non-AI workforce26099.24%
Web traffic by country
15K
monthly visits
across markets
across markets
🇺🇸 United States37.3%
🇮🇳 India24%
🇳🇱 Netherlands11.3%
🇬🇧 United Kingdom10%
🇭🇰 Hong Kong8.7%
Patent intelligence
$172M patent portfolio · 102 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$172M
2.8% of market cap · 11.8× smaller than top peer Ablynx ($2B)
102 active patent families
Where Merus innovates
Molecular biologyCarcinosisCancer researchAntiendomysial antibodiesBinding domain
Above peer median on Legal
Quality vs same-sector peers
Merus on the five Patsnap quality dimensions
Merus in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Merus concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Merus and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Merus on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.